Pasar al contenido principal

BIOMATERIALES DE PRECISION BIOINGENIERIZADOS PARA ESTRATEGIAS DE LIBERACION CONTROLADA DE FARMACOS DIRIGIDA

PID2019-106386RB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2019
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDAD DE VALLADOLID

Resultados relacionados

Resultados totales (Incluyendo duplicados): 4
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Silk-elastin-like polymers for acute intraparenchymal treatment of the traumatically injured spinal cord: a first systematic experimental approach

  • González, Pau
  • González-Fernández, Carlos
  • Maqueda, Alfredo
  • Pérez, Virginia
  • Escalera-Anzola, Sara
  • Rodríguez de Lope, Ángel
  • Arias, Francisco Javier
  • Girotti, Alessandra
  • Rodríguez, Francisco Javier
Despite the promising potential of hydrogel-based therapeutic approaches for spinal cord injury (SCI), the need for new biomaterials to design effective strategies for SCI treatment and the outstanding properties of silk-elastin-like polymers (SELP), the potential use of SELPs in SCI is currently unknown. In this context, we assessed the effects elicited by the in vivo acute intraparenchymal injection of an SELP named (EIS)2-RGD6 in a clinically relevant model of SCI. After optimization of the injection system, the distribution, structure, biodegradability, and cell infiltration capacity of (EIS)2-RGD6 were assessed. Finally, the effects exerted by the (EIS)2-RGD6 injection—in terms of motor function, myelin preservation, astroglial and microglia/macrophage reactivity, and fibrosis—were evaluated. We found that (EIS)2-RGD6 can be acutely injected in the lesioned spinal cord without inducing further damage, showing a widespread distribution covering all lesioned areas with a single injection and facilitating the formation of a slow-degrading porous scaffold at the lesion site that allows for the infiltration and/or proliferation of endogenous cells with no signs of collapse and without inducing further microglial and astroglial reactivity, as well as even reducing SCI-associated fibrosis. Altogether, these observations suggest that (EIS)2-RGD6—and, by extension, SELPs—could be promising polymers for the design of therapeutic strategies for SCI treatment., This work has been supported by the “Instituto de Salud Carlos III” (Grants number DTS19/00129 and DTS19/00162; ERDF co-funded), the MICINN/AEI/10.13039/501100011033 and PID2019-106386RB-I00 and by “ERDF A way of making Europe” (Grant number RTI2018-097775-BI00) and the “Consejería de Educación, Cultura y Deportes de la Junta de Comunidades de Castilla-La Mancha” (Grant number SBPLY/19/180501/000275; ERDF co-funded). CGF was funded by “Junta de Comunidades de Castilla-La Mancha/Convocatoria de Ayudas Regionales a la Investigación en Biomedicina y Ciencias de la Salud” (Grant II-2020/03 for incorporation of postdoctoral researchers). SEA was funded by MICINN (Ref. number: BES-2017-082345)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Functionalization of 3D-Printed Titanium Scaffolds with Elastin-like Recombinamers to Improve Cell Colonization and Osteoinduction

  • Guillem-Marti, Jordi
  • Vidal, Elia
  • Girotti, Alessandra
  • Heras-Parets, Aina
  • Torres, Diego
  • Arias, Francisco Javier
  • Ginebra, Maria-Pau
  • Rodriguez-Cabello, Jose Carlos
  • Manero, Jose Maria
The 3D printing of titanium (Ti) offers countless possibilities for the development of personalized implants with suitable mechanical properties for different medical applications. However, the poor bioactivity of Ti is still a challenge that needs to be addressed to promote scaffold osseointegration. The aim of the present study was to functionalize Ti scaffolds with genetically modified elastin-like recombinamers (ELRs), synthetic polymeric proteins containing the elastin epitopes responsible for their mechanical properties and for promoting mesenchymal stem cell (MSC) recruitment, proliferation, and differentiation to ultimately increase scaffold osseointegration. To this end, ELRs containing specific cell-adhesive (RGD) and/or osteoinductive (SNA15) moieties were covalently attached to Ti scaffolds. Cell adhesion, proliferation, and colonization were enhanced on those scaffolds functionalized with RGD-ELR, while differentiation was promoted on those with SNA15-ELR. The combination of both RGD and SNA15 into the same ELR stimulated cell adhesion, proliferation, and differentiation, although at lower levels than those for every single moiety. These results suggest that biofunctionalization with SNA15-ELRs could modulate the cellular response to improve the osseointegration of Ti implants. Further investigation on the amount and distribution of RGD and SNA15 moieties in ELRs could improve cell adhesion, proliferation, and differentiation compared to the present study., This research was funded by the Ministry of Science and Innovation of Spain through the projects PID2021-125150OB-I00, DTS19/00162, and PID2019-106386RB-I00, cofounded by the EU through the European Regional Development Funds (MINECO/FEDER, EU). M.-P.G. acknowledges the Generalitat de Catalunya for the ICREA Academia Award.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

CD44-targeted nanoparticles for co-delivery of docetaxel and an Akt inhibitor against colorectal cancer

  • Gonzalez-Valdivieso, Juan
  • Vallejo, Reinaldo
  • Rodriguez-Rojo, Soraya
  • Santos, Mercedes
  • Schneider, Jose
  • Arias, Francisco Javier
  • Girotti, Alessandra
New strategies to develop drug-loaded nanocarriers with improved therapeutic efficacy are needed for cancer treatment. Herein we report a novel drug-delivery nanosystem comprising encapsulation of the chemotherapeutic drug docetaxel (DTX) and recombinant fusion of a small peptide inhibitor of Akt kinase within an elastin-like recombinamer (ELR) vehicle. This combined approach is also precisely targeted to colorectal cancer cells by means of a chemically conjugated DNA aptamer specific for the CD44 tumor marker. This 53 nm dual-approach nanosystem was found to selectively affect cell viability (2.5 % survival) and proliferation of colorectal cancer cells in vitro compared to endothelial cells (50 % survival), and to trigger both apoptosis- and necrosis-mediated cell death. Our findings also show that the nanohybrid particles remain stable under physiological conditions, trigger sustained drug release and possess an adequate pharmacokinetic profile after systemic intravenous administration. In vivo assays showed that these dual-approach nanohybrids significantly reduced the number of tumor polyps along the colorectal tract in a murine colorectal cancer model. Furthermore, systemic administration of advanced nanohybrids induced tissue recovery by improving the morphology of gastrointestinal crypts and the tissue architecture. Taken together, these findings indicate that our strategy of an advanced dual-approach nanosystem allows us to achieve successful controlled release of chemotherapeutics in cancer cells and may have a promising potential for colorectal cancer treatment., The authors are grateful for financial support from the European Social Fund (ESF), the European Regional Development Fund (ERDF) and the MICIUN (DTS19/00162 and PID2019-106386RB-I00). Soraya Rodriguez-Rojo would like to thank the University of Valladolid for her postdoctoral contract., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Acetazolamide encapsulation in elastin like recombinamers using a supercritical antisolvent (SAS) process for glaucoma treatment

  • Vallejo, Reinaldo
  • Quinteros, Daniela
  • Gutiérrez, Javier
  • Martínez, Sofía
  • Rodriguez-Rojo, Soraya
  • Tártara, Luis Ignacio
  • Palma, Santiago
  • Arias, Francisco Javier
Glaucoma, the second most common cause of blindness worldwide, requires the development of new and effective treatments. This study introduces a novel controlled-release system utilizing elastin-like recombinamers (ELR) and the Supercritical Antisolvent (SAS) technique with supercritical CO2. Acetazolamide (AZM), a class IV drug with limited solubility and permeability, is successfully encapsulated in an amphiphilic ELR at three different ELR:AZM ratios, yielding up to 62 %. Scanning electron microscopy (SEM) reveals spherical microparticles that disintegrate into monodisperse nanoparticles measuring approximately 42 nm under physiological conditions. The nanoparticles, as observed via Transmission Electron Microscopy (TEM) and Atomic Force Microscopy (AFM), do not exhibit aggregates, a fact confirmed by the zeta potential displaying a value of –33 mV over a period of 30 days. Transcorneal permeation tests demonstrate a 10 % higher permeation level compared to the control solution, which increases to 30 % after 2 h. Ocular irritation tests demonstrate no adverse effects or damage. Intraocular pressure (IOP) tests conducted on hypertensive rabbits indicate greater effectiveness for all three analyzed formulations, suggesting enhanced drug bioavailability during treatment. Consequently, the combination of recombinant biopolymers and high-pressure techniques represents a promising approach for advancing glaucoma therapy, emphasizing its potential clinical significance., The authors are grateful for financial support from the MINECO (PID2019-106386RB-I00). The authors wish to acknowledge the assistance of the Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Universidad Nacional de Córdoba and University of Valladolid for having provided support and facilities for this investigation Soraya Rodríguez Rojo thanks the University of Valladolid for her postdoctoral contract., Peer reviewed